894P Diffuse large B-cell testicular lymphomas (DLBCL-TL): Survival outcomes over 20 years

Abstract

Background: Diffuse Large B-Cell Lymphoma (DLBCL) is the most frequent type of Non-Hodgkin Lymphoma (NHL). Up to 40% of patients will relapse in the following years with a poor prognosis. Overall Survival (OS) of patients with DLBCL has a wide range depending on the stage and response of the patient. Molecular characteristics could influence the course of DLBCL. Until now, few relevant genetic alterations were known. This is the case of translocations in BCL-2, BCL-6 and MYC whose worse prognosis is a well known fact although they do not change the treatment. The